Advertisement Perrigo acquires Laboratorios Diba - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Perrigo acquires Laboratorios Diba

Perrigo Company, a healthcare supplier, has acquired Mexico-based Laboratorios Diba, a store brand manufacturer of over-the-counter and prescription pharmaceuticals, for approximately $25 million in cash. The acquisition is expected to add nearly $15 million of annual sales.

Joseph Papa, chairman and CEO of Perrigo, said: “The acquisition of Laboratorios Diba will enable us to market an additional 150 formulas and 50 trademarks into the rapidly growing Mexican store brand market, saving consumers money on their healthcare options. This further exemplifies Perrigo’s commitment to meeting the growing need for quality, affordable healthcare around the world.”